Senores Pharmaceuticals Limited IPO

Senores Pharmaceuticals Limited is listed in the MAINBOARD segment with a price band of ₹372 to ₹391. The figures below are as reported by the exchanges and public sources.

Senores Pharmaceuticals Limited IPO — key facts

• The Senores Pharmaceuticals Limited IPO price band is ₹372 to ₹391 per share.
• As of 6 September 2026, the Senores Pharmaceuticals Limited IPO subscription status is 97.86x overall.
• The issue is open from 20-DEC-2024 to 24-DEC-2024.
• Senores Pharmaceuticals Limited listed on 30-DEC-2024.
• Senores Pharmaceuticals Limited listed at ₹557.8. The listing gain was 42.7% against the upper end of the issue price band.

Senores Pharmaceuticals Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹372 – ₹391

Issue size

₹582.11 Cr

Fresh issue

₹500 Cr

Offer for sale

₹82.11 Cr

Opens

20-DEC-2024

Closes

24-DEC-2024

Listing

30-DEC-2024

Total subscription

97.86x

Retail

93.16x

QIB

97.84x

NII

100.35x

Lead managers

Equirus Capital (left lead)

Listing price

₹557.8

Listing day change

+42.7%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.